Underlying Ebitda increased 6% on a sequential basis, driven by the company’s specialty polymers, Novecare and composite materials businesses.
Source link
Syensqo Shares Jump on Better-Than-Expected Adjusted Earnings
Date:
Date:
Underlying Ebitda increased 6% on a sequential basis, driven by the company’s specialty polymers, Novecare and composite materials businesses.
Source link